We’re excited to announce that Quantics will be attending BEBPA’s virtual 14th Annual EUR Bioassay Conference from September 20th-23rd, 2021.
We look forward to joining expert discussion focused on best practices for the best potency assays.
Don’t miss the talk by Brooke Franklin, Quantics Statistician, on using simulation to reduce lab work on 22nd September at 16:15 (BST). See the full conference schedule here:
Abstract: During development, scientists often repeat or rerun assay work, especially with cell-based potency assays with inherent variability. These repeats take time, resources and the cost can add up. Quantics encourage our clients to consider simulation to drastically reduce repetition. Simulating assay conditions can be done in either development or routine work and can help to define optimal doses, predict reference standard degradation, and more. Simulation is invaluable in drug development. Join us to discuss what it is, how it can be used and how it can save you time, money and a lot of extra, unnecessary laboratory work.